Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

<p>Abstract</p> <p>Background</p> <p>Hypertriglyceridemia in combination with low HDL cholesterol levels is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of ciprofibrate for the treatment of this form of dyslipidemia and to identif...

Full description

Bibliographic Details
Main Authors: Medel Octavio, Hernández Ismael, Salinas Saul, Vazquez Cuauhtémoc, Ramírez Erika, Jiménez Sergio, Hernández Ma, Florenzano Fernando, Saavedra Victor, Reyes Eliana, Machado Carlos, Oliveira José, Torres Kerginaldo, Rabelo Lísia, Neto Abrahão, Filho José, Rengifo Hector, Stockins Benjamín, Aguilar-Salinas Carlos A, Assis-Luores-Vale Andréia, Moreno Ricardo, Lugo Paula, Alvarado Ricardo, Mehta Roopa, Gutierrez Victor, Gómez Pérez Francisco J
Format: Article
Language:English
Published: BMC 2004-07-01
Series:Cardiovascular Diabetology
Subjects:
Ciprofibrate
obesity
HDL cholesterol
triglycerides
fibrates
Online Access:http://www.cardiab.com/content/3/1/8

Internet

http://www.cardiab.com/content/3/1/8

Similar Items